ALHC Form 144: Multiple Insider Sales Listed

Alignment Healthcare, Inc. reported proposed and recent sales of its common stock by a trust and an individual in a Form 144 disclosure.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. reported proposed and recent sales of its common stock by a trust and an individual in a Form 144 disclosure. The filing lists multiple 10b5-1 plan sales including 180,000 shares on 03/10/2026, 180,000 on 02/10/2026, 180,000 on 01/12/2026, and a 605,648-share sale on 12/29/2025. It also shows 124,172 shares acquired from RSU vesting on 03/08/2022.

Insights

Insider Transactions Analyst

Form 144 lists multiple planned and completed sales under a 10b5-1 plan and an individual sale.

The filing shows recurring 10b5-1 plan sales by JEK Trust — three entries of 180,000 shares each on 01/12/2026, 02/10/2026, and 03/10/2026 — and a separate 605,648-share sale recorded on 12/29/2025. These are reported dispositions of Common Stock.

Cash‑flow treatment and buyer identities are not stated in the excerpt; timing and pattern suggest systematic plan activity. Subsequent filings or broker statements would show net proceeds and any remaining plan limits.

Securities Compliance Counsel

Transactions are reported under Rule 144 and reference a 10b5-1 sales plan and RSU vesting.

The disclosure cites an RSU vesting event of 124,172 shares on 03/08/2022 and identifies a 10b5-1 Sales Plan for JEK Trust dated 02/08/2021. The filing lists the Nasdaq as the market for the securities.

Relevant qualifiers (plan name, trust document date) are included verbatim. Any regulatory compliance implications depend on trade execution details and are not specified in the provided excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales does Alignment Healthcare (ALHC) disclose in this Form 144?

The Form 144 lists several dispositions of Common Stock, including 180,000 shares on 03/10/2026 and a 605,648-share sale on 12/29/2025. It also notes RSUs vesting of 124,172 shares on 03/08/2022.

Who executed the sales reported in the Form 144 for ALHC?

The excerpt attributes multiple sales to the JEK Trust U/A DTD 02/08/2021 under a 10b5-1 plan and records a sale by John Kao on 12/29/2025. No purchaser identities are provided in the excerpt.

Do the filings show whether the sales were under a 10b5-1 plan?

Yes. Several entries explicitly reference a 10b5-1 Sales Plan for JEK Trust U/A DTD 02/08/2021, with repeated 180,000-share transactions listed on 01/12/2026, 02/10/2026, and 03/10/2026.

Were any shares acquired by vesting noted in the Form 144?

The filing records that 124,172 shares of Common Stock were acquired through the vesting of restricted stock units on 03/08/2022 under the issuer's 2021 Equity Incentive Plan.

Does the Form 144 state how much cash was received from the sales?

The provided excerpt does not disclose net proceeds. It lists share counts and dates for each disposition, but cash amounts or buyer identities are not shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 07:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001222028
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alignment Healthcare, Inc.
SEC File Number	001-40295
Address of Issuer	1100 W. Town & Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	844-310-2247
Name of Person for Whose Account the Securities are To Be Sold	John Kao
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Executive Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	50000	922000	204296493	03/11/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/08/2022	The Common Stock was acquired through the vesting of restricted stock units granted on 03/08/2022 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			124172	03/08/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	03/10/2026	180000	3273552
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	02/10/2026	180000	3687354
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/12/2026	180000	3799218.96
John Kao 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/29/2025	605648	11351466.51
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/10/2025	180000	3423222

144: Remarks and Signature

Remarks	Shares sold pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person. Actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale.
Date of Notice	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Kao
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)